Bottles of hemp-derived oils sit behind glass, under lock and key, at Alfalfa’s natural foods store in Boulder, Colo.
Some 2,000 miles away from cannabis-friendly Colorado, a Naples, Fla., Lucky’s Market displays nearly a dozen brands of CBD-rich extracts, powders and salves.
These traditional retailers either could be offering a glimpse into the future where CBD products are sold like fish oil, or they could be enjoying a fleeting moment in the course of history for the non-psychoactive cannabis compound.
As health food grocers such as Alfalfa’s and Lucky’s stock CBD products on store shelves, a novel cannabis-based pharmaceutical product that could upend the cottage industry is chugging through the U.S. Food and Drug Administration approval pipeline.
But it’s not just the FDA that will decide how hemp-derived, cannabinoid-rich products should be classified and whether they can be legally sold.